Filtered By:
Infectious Disease: SARS
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 1917 results found since Jan 2013.
Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination
This study aimed to retrospectively evaluate the role of polyethylene glycol (PEG) sensitivity in vaccination decision-making in pediatric patients at high risk of allergy or with suspected allergic reactions to the first dose of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine. Seventeen enrolled patients were found to have decreased readiness to receive the Coronavirus Disease 2019 (COVID-19) vaccine after developing hypersensitivity to multiple and/or injectable drugs. Skin testing was performed. A basophil activation test with PEG-2000 and 4000 was performed on three patients who were ineligible ...
Source: Allergologia et Immunopathologia - May 11, 2023 Category: Allergy & Immunology Authors: Betul Gemici Karaaslan Nihan Burtecene Ulviye Mustu Suheyla Ocak Ozgur Kasapcopur Ayca K ıykım Haluk Cokugras Source Type: research
NIH restarts bat virus grant suspended 3 years ago by Trump
Three years after then-President Donald Trump pressured the National Institutes of Health (NIH) to suspend a research grant to a U.S. group studying bat coronaviruses with partners in China, the agency has restarted the award.
The new 4-year grant is a stripped-down version of the original grant to the EcoHealth Alliance, a nonprofit research organization in New York City, providing $576,000 per year. That 2014 award included funding for controversial experiments that mixed parts of different bat viruses related to severe acute respiratory syndrome (SARS), the coronavirus that sparked a global outbreak in 2002–04, a...
Source: ScienceNOW - May 8, 2023 Category: Science Source Type: news
Why It Took So Long to Finally Get an RSV Vaccine
Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers for Disease Control’s vaccine committee will make formal recommendations in June about who should receive the vaccine, but GSK says it currently has enough doses to vaccinate eligible people beginning this fall.
In studies involving 25,000 people that GSK...
Source: TIME: Health - May 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
COVID-19 infection and vaccination in patients with hereditary angioedema: a multicentric study
Conclusions. Patients with HAE can safely receive COVID-19 vaccination. The severity of COVID-19 infection does not appear to be increased in HAE patients.PMID:37133310 | DOI:10.23822/EurAnnACI.1764-1489.295
Source: European Annals of Allergy and Clinical Immunology - May 3, 2023 Category: Allergy & Immunology Authors: I F da Costa Farinha M B Gaspar de Paiva Neto Freitas Tavares N A Gaspar de Sousa E Matos Marques Almeida C Lozoya Ib áñez F E de Castro Soares Regateiro A M Pego Todo-Bom Ferreira da Costa E M Antunes Gomes de Faria Source Type: research
